Inactive Instrument

Company Nuvo Pharmaceuticals Inc.

Equities

MRV

CA67092F1045

Pharmaceuticals

Business Summary

Nuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, is a Canada-based healthcare company. The Company's products target several therapeutic areas, including pain, allergy, neurology and dermatology. Its segments include Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment offers products with promotional efforts, such as Blexten, Cambia, Suvexx and NeoVisc , as well as a number of mature products. The Production and Service Business segment includes the sale of products manufactured by the Company from its manufacturing facility in Varennes, Quebec or contracted by Miravo Ireland from its international headquarters in Dublin, Ireland, as well as service for testing, development and related quality assurance and quality control services provided by the Company. The Licensing and Royalty Business segment includes the licensing of intellectual property and ongoing royalties from licensing agreements.

Number of employees: 101

Managers

Managers TitleAgeSince
Chief Executive Officer - 16-04-05
Director of Finance/CFO - 11-12-31
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - -
Director/Board Member - -
Corporate Officer/Principal - 18-12-31
Corporate Officer/Principal - -
General Counsel - 07-12-31

Members of the board

Members of the board TitleAgeSince
Chairman 69 17-04-04
Director/Board Member - 04-09-20
Director/Board Member - -
Director/Board Member 67 21-05-16
Director/Board Member 49 22-08-11
Director/Board Member 68 22-05-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,388,000 10,851,712 ( 95.29 %) 0 95.29 %

Company contact information

Nuvo Pharmaceuticals, Inc.

6733 Mississauga Road Suite 800

L5N 6J5, Mississauga

+

http://www.miravohealthcare.com
address Nuvo Pharmaceuticals Inc.(MRV)
  1. Stock Market
  2. Equities
  3. MRV Stock
  4. Company Nuvo Pharmaceuticals Inc.